PE20020855A1 - Derivados de piperazina azaindoloxoacetico sustituidos con actividad antiviral - Google Patents
Derivados de piperazina azaindoloxoacetico sustituidos con actividad antiviralInfo
- Publication number
- PE20020855A1 PE20020855A1 PE2002000075A PE2002000075A PE20020855A1 PE 20020855 A1 PE20020855 A1 PE 20020855A1 PE 2002000075 A PE2002000075 A PE 2002000075A PE 2002000075 A PE2002000075 A PE 2002000075A PE 20020855 A1 PE20020855 A1 PE 20020855A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- cycloalkyl
- heteroaryl
- aryl
- antiviral activity
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- -1 CYANE Chemical class 0.000 abstract 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 229960005475 antiinfective agent Drugs 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000002835 hiv fusion inhibitor Substances 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 230000002584 immunomodulator Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
SE REFIERE A DERIVADOS DE AZAINDOLOXOACETIL-PIPERAZIN DIAMIDA DE FORMULA I DONDE Q ES UN GRUPO a, b; R1, R2, R3, R4 SON H, HALOGENO, CIANO, NITRO, COOR8, B, D, E; UNO DE R1-R4 ES B, E; m ES 1-2; R5 ES H, (CH2)nR44; n ES 0-6; R6 ES O, A ES ALCOXI C1-C6, ARILO, HETEROARILO, W ES UN GRUPO c; B ES ARILO, HETEROARILO, ENTRE OTROS; q ES 0-2; D ES ALQUILO C1-C6, CICLOALQUILO C3-C7, ALQUENILO C2-C6, ENTRE OTROS; E ES ALQUILO C1-C6, CICLOALQUILO C3-C7, ALQUENILO C2-C6, ENTRE OTROS; F ES ALQUILO C1-C6, CICLOALQUILO C3-C7, ARILO, HETERARILO, ENTRE OTROS; G ES ALQUILO C1-C6, CICLOALQUILO C3-C7, ARILO, HETEROARILO, OH, ENTRE OTROS; R7 ES ARILO, HETEROARILO, HETEROALICICLICO; R8 ES H, ALQUILO C1-C6, CICLOALQUILO C3-C7, ENTRE OTROS; R9, R10, R11, R12, R13, R14, R15, R16 SON H, ALQUILO C1-C6; X ES NR5, O, S; R40, R41 SON H, ALQUILO C1-C6, CICLOALQUILO C3-C7, ENTRE OTROS; R42 Y R43 SON H, ALQUILO C1-C6, ALCOXI C1-C6, ALQUENILO C2-C6, ENTRE OTROS; R44 ES H, ALQUILO C1-C6, CICLOALQUILO C3-C6, ENTRE OTROS; T ES S, O; Ar ES FENILO, HETEROARILO, Ra Y Rb SON H, ALQUILO C1-C6, FENILO; R46 ES H, OR7, NR40R41; R50 ES H, ALQUILO C1-C6, CICLOALQUILO C3-C6, ENTRE OTROS; R51 ES H, ALQUILO C1-C6, CICLOALQUILO C3-C6, ENTRE OTROS; Y ES O, S, NR50R51. TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE ADEMAS UN ANTIVIRAL CONTRA EL SIDA, UN AGENTE ANTIINFECCIOSO, UN INMUNOMODULADOR, INHIBIDORES DE ENTRADA DEL VIH. LOS COMPUESTOS TIENEN ACTIVIDAD ANTIVIRAL Y PUEDEN SER UTILES PARA EL TRATAMIENTO DEL VIH, SIDA
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26618301P | 2001-02-02 | 2001-02-02 | |
| US31440601P | 2001-08-23 | 2001-08-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020855A1 true PE20020855A1 (es) | 2002-09-27 |
Family
ID=26951680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000075A PE20020855A1 (es) | 2001-02-02 | 2002-02-01 | Derivados de piperazina azaindoloxoacetico sustituidos con actividad antiviral |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20030069266A1 (es) |
| EP (1) | EP1363705B9 (es) |
| JP (1) | JP4328527B2 (es) |
| KR (1) | KR20030079979A (es) |
| CN (1) | CN100384423C (es) |
| AR (1) | AR034292A1 (es) |
| BG (1) | BG66359B1 (es) |
| BR (1) | BRPI0206636B8 (es) |
| CA (1) | CA2437524C (es) |
| CY (1) | CY1113194T1 (es) |
| CZ (1) | CZ303750B6 (es) |
| DK (1) | DK1363705T3 (es) |
| EE (1) | EE05424B1 (es) |
| ES (1) | ES2387981T3 (es) |
| HR (1) | HRP20030694A2 (es) |
| HU (1) | HU229305B1 (es) |
| IL (2) | IL157029A0 (es) |
| IS (1) | IS2912B (es) |
| MX (1) | MXPA03006939A (es) |
| MY (1) | MY137480A (es) |
| NO (1) | NO326510B1 (es) |
| NZ (1) | NZ527193A (es) |
| PE (1) | PE20020855A1 (es) |
| PL (1) | PL364279A1 (es) |
| PT (1) | PT1363705E (es) |
| RS (1) | RS52489B (es) |
| RU (1) | RU2303038C2 (es) |
| SK (1) | SK287900B6 (es) |
| TW (1) | TWI318978B (es) |
| WO (1) | WO2002062423A1 (es) |
| ZA (1) | ZA200305885B (es) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6476034B2 (en) * | 2000-02-22 | 2002-11-05 | Bristol-Myers Squibb Company | Antiviral azaindole derivatives |
| US20030207910A1 (en) * | 2001-02-02 | 2003-11-06 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US20040110785A1 (en) * | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US20040162298A1 (en) * | 2002-02-23 | 2004-08-19 | Hsu-Tso Ho | Method of treating HIV infection by preventing interaction of CD4 and gp120 |
| US7348337B2 (en) | 2002-05-28 | 2008-03-25 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| US6900206B2 (en) | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| ATE441417T1 (de) | 2002-12-20 | 2009-09-15 | Glaxo Group Ltd | Benzoädüazepinderivate für die behandlung von neurologischen krankheiten |
| US20050075364A1 (en) * | 2003-07-01 | 2005-04-07 | Kap-Sun Yeung | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
| US20050124623A1 (en) * | 2003-11-26 | 2005-06-09 | Bender John A. | Diazaindole-dicarbonyl-piperazinyl antiviral agents |
| UA88297C2 (ru) * | 2004-03-15 | 2009-10-12 | Бристол-Майэрс Сквибб Компани | Пиперазиновые пролекарства и замещенные пиперидиновые антивирусные средства |
| US7745625B2 (en) * | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
| WO2005121140A1 (en) | 2004-06-09 | 2005-12-22 | Glaxo Group Limited | Pyrrolopyridine derivatives |
| MX2007002219A (es) | 2004-09-03 | 2007-05-04 | Yuhan Corp | Derivados de pirrolo [3,2-b ] piridina y procesos para su preparacion. |
| US20060100432A1 (en) * | 2004-11-09 | 2006-05-11 | Matiskella John D | Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| US20060100209A1 (en) * | 2004-11-09 | 2006-05-11 | Chong-Hui Gu | Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| US7183284B2 (en) * | 2004-12-29 | 2007-02-27 | Bristol-Myers Squibb Company | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| US7601715B2 (en) | 2005-06-22 | 2009-10-13 | Bristol-Myers Squibb Company | Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
| US7396830B2 (en) * | 2005-10-04 | 2008-07-08 | Bristol-Myers Squibb Company | Piperazine amidines as antiviral agents |
| US7851476B2 (en) * | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
| US7807671B2 (en) | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
| US7504399B2 (en) * | 2006-06-08 | 2009-03-17 | Bristol-Meyers Squibb Company | Piperazine enamines as antiviral agents |
| EP2046753A2 (en) * | 2006-07-06 | 2009-04-15 | Brystol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| JP5351025B2 (ja) * | 2006-09-22 | 2013-11-27 | ノバルティス アーゲー | ヘテロ環式有機化合物 |
| ES2389478T3 (es) | 2008-06-25 | 2012-10-26 | Bristol-Myers Squibb Company | Derivados de dicetopiperidina como inhibidores de la fijación del VIH |
| CN102131810B (zh) | 2008-06-25 | 2014-02-26 | 百时美施贵宝公司 | 作为抗hiv剂的二酮稠合的吡咯并哌啶类和吡咯并哌嗪类 |
| US8450361B2 (en) | 2010-08-06 | 2013-05-28 | Bristol-Myers Squibb Company | Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
| US8912195B2 (en) | 2010-12-02 | 2014-12-16 | Bristol-Myers Squibb Company | Alkyl amides as HIV attachment inhibitors |
| EP2696937B1 (en) | 2011-04-12 | 2017-05-17 | VIIV Healthcare UK (No.5) Limited | Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors |
| WO2013033061A1 (en) | 2011-08-29 | 2013-03-07 | Bristol-Myers Squibb Company | Fused bicyclic diamine derivatives as hiv attachment inhibitors |
| EP2751118B1 (en) | 2011-08-29 | 2016-10-12 | Bristol-Myers Squibb Company | Spiro bicyclic diamine derivatives as hiv attachment inhibitors |
| US8889869B2 (en) * | 2012-02-08 | 2014-11-18 | Bristol-Myers Squibb Company | Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound |
| WO2013138436A1 (en) | 2012-03-14 | 2013-09-19 | Bristol-Myers Squibb Company | Cyclolic hydrazine derivatives as hiv attachment inhibitors |
| WO2014060381A1 (de) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclische verbindungen als schädlingsbekämpfungsmittel |
| US20150284380A1 (en) | 2012-10-31 | 2015-10-08 | Bayer Cropscience Ag | Novel heterocyclic compounds as pest control agents |
| WO2016004305A2 (en) | 2014-07-02 | 2016-01-07 | Pharmacyclics Llc | Inhibitors of bruton's tyrosine kinase |
| AR119174A1 (es) | 2019-06-19 | 2021-12-01 | Viiv Healthcare Uk No 5 Ltd | Inhibidores de la replicación del virus de inmunodeficiencia humana |
| US11862306B1 (en) | 2020-02-07 | 2024-01-02 | Cvs Pharmacy, Inc. | Customer health activity based system for secure communication and presentation of health information |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5563142A (en) * | 1989-12-28 | 1996-10-08 | The Upjohn Company | Diaromatic substituted compounds as anti-HIV-1 agents |
| FR2674856B1 (fr) * | 1991-04-05 | 1993-07-30 | Esteve Labor Dr | Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments. |
| GB9420521D0 (en) * | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
| TW406075B (en) * | 1994-12-13 | 2000-09-21 | Upjohn Co | Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds |
| AU772295B2 (en) * | 1999-05-21 | 2004-04-22 | Scios Inc. | Indole-type derivatives as inhibitors of p38 kinase |
| US6469006B1 (en) * | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
| HUP0203375A3 (en) * | 1999-07-28 | 2005-03-29 | Aventis Pharm Prod Inc | Substituted oxoazaheterocyclyl compounds |
| IL150388A0 (en) * | 1999-12-24 | 2002-12-01 | Aventis Pharma Ltd | Azaindoles |
| US20020061892A1 (en) * | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
| DK1299382T3 (da) * | 2000-07-10 | 2006-01-16 | Bristol Myers Squibb Co | Præparat og antiviral virkning af substituerede indoloxoeddikesyrepiperazinderivater |
| US6825201B2 (en) * | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
-
2002
- 2002-01-02 SK SK959-2003A patent/SK287900B6/sk not_active IP Right Cessation
- 2002-01-02 CN CNB028078268A patent/CN100384423C/zh not_active Expired - Lifetime
- 2002-01-02 HR HR20030694A patent/HRP20030694A2/hr not_active Application Discontinuation
- 2002-01-02 HU HU0304062A patent/HU229305B1/hu unknown
- 2002-01-02 RS YU60903A patent/RS52489B/sr unknown
- 2002-01-02 CZ CZ20032316A patent/CZ303750B6/cs not_active IP Right Cessation
- 2002-01-02 NZ NZ527193A patent/NZ527193A/en not_active IP Right Cessation
- 2002-01-02 WO PCT/US2002/000455 patent/WO2002062423A1/en not_active Ceased
- 2002-01-02 DK DK02707413.7T patent/DK1363705T3/da active
- 2002-01-02 PT PT02707413T patent/PT1363705E/pt unknown
- 2002-01-02 BR BRPI0206636-0 patent/BRPI0206636B8/pt not_active IP Right Cessation
- 2002-01-02 EE EEP200300359A patent/EE05424B1/xx unknown
- 2002-01-02 JP JP2002562428A patent/JP4328527B2/ja not_active Expired - Lifetime
- 2002-01-02 KR KR10-2003-7010208A patent/KR20030079979A/ko not_active Withdrawn
- 2002-01-02 US US10/038,306 patent/US20030069266A1/en not_active Abandoned
- 2002-01-02 ES ES02707413T patent/ES2387981T3/es not_active Expired - Lifetime
- 2002-01-02 CA CA2437524A patent/CA2437524C/en not_active Expired - Lifetime
- 2002-01-02 RU RU2003127077/04A patent/RU2303038C2/ru active
- 2002-01-02 PL PL02364279A patent/PL364279A1/xx unknown
- 2002-01-02 EP EP02707413A patent/EP1363705B9/en not_active Expired - Lifetime
- 2002-01-02 MX MXPA03006939A patent/MXPA03006939A/es active IP Right Grant
- 2002-01-02 IL IL15702902A patent/IL157029A0/xx unknown
- 2002-01-18 MY MYPI20020202A patent/MY137480A/en unknown
- 2002-01-23 TW TW091101013A patent/TWI318978B/zh not_active IP Right Cessation
- 2002-01-31 AR ARP020100336A patent/AR034292A1/es active IP Right Grant
- 2002-02-01 PE PE2002000075A patent/PE20020855A1/es not_active Application Discontinuation
-
2003
- 2003-07-21 IL IL157029A patent/IL157029A/en active IP Right Grant
- 2003-07-22 BG BG108021A patent/BG66359B1/bg unknown
- 2003-07-30 IS IS6899A patent/IS2912B/is unknown
- 2003-07-30 ZA ZA2003/05885A patent/ZA200305885B/en unknown
- 2003-08-01 NO NO20033436A patent/NO326510B1/no not_active IP Right Cessation
-
2012
- 2012-09-12 CY CY20121100828T patent/CY1113194T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020855A1 (es) | Derivados de piperazina azaindoloxoacetico sustituidos con actividad antiviral | |
| PE20020786A1 (es) | Derivados de azaindol antiviral | |
| PE20081448A1 (es) | Inhibidores de transcriptasa inversa no nucleosidicos | |
| AR048315A1 (es) | Compuestos heterociclicos inhibidores de la produccion de citocinas; composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades inflamatorias y oncologicas. | |
| MA31419B1 (fr) | Derives de pyridine | |
| TNSN07022A1 (fr) | Derives de pyridine | |
| PE20130209A1 (es) | Derivados de uracilo o timina para tratar la hepatitis c | |
| PE20010286A1 (es) | Derivados de indoloxoacetil piperazina como agentes antivirales | |
| PE20121157A1 (es) | Compuestos heterociclicos como inhibidores de proteasas serinas | |
| AR030432A1 (es) | Uso de derivados de quinazolina en la preparacion de un medicamento para ser usado en la inhibicion de la quinasa aurora2, compuestos relacionados, y composicion farmaceutica. | |
| PE20070211A1 (es) | Compuestos macrociclicos como inhibidores del virus de hepatitis c | |
| PE20061106A1 (es) | Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida | |
| PE20060691A1 (es) | Serinamidas sustituidas por benzoilo | |
| PE20010546A1 (es) | Uso de una composicion de benzoheterociclos como inhibidores de mek para tratar el dolor cronico | |
| PE20030012A1 (es) | Composicion y actividad antiviral de derivados de indoloxoacetico piperazina sustituidos | |
| CY1108714T1 (el) | Ανταγωνιστες υποδοχεα cgrp | |
| AR070811A1 (es) | Derivados de 1- bencil-3- hidroximetilindazol y su utilizacion en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40 | |
| NO20070258L (no) | Benzyltriazolonforbindelser som ikke-nukleoside revers transkriptase inhibitorer | |
| PE20091466A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il-amina | |
| AR038476A1 (es) | Derivados de quinazolina | |
| AR038703A1 (es) | Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3 | |
| TW200505453A (en) | Non-nucleoside reverse transcriptase inhibitors | |
| MX2009009920A (es) | Inhibidores no nucleosidos de transcriptasa inversa. | |
| HUP0402025A2 (hu) | Új benzofenon származékok és sóik és alkalmazásuk | |
| MA29926B1 (fr) | Derives de pyrazine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |